Correlation Between Cingulate Warrants and Xeris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Xeris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Xeris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Xeris Pharmaceuticals, you can compare the effects of market volatilities on Cingulate Warrants and Xeris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Xeris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Xeris Pharmaceuticals.
Diversification Opportunities for Cingulate Warrants and Xeris Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Cingulate and Xeris is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Xeris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xeris Pharmaceuticals and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Xeris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xeris Pharmaceuticals has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Xeris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Xeris Pharmaceuticals
Assuming the 90 days horizon Cingulate Warrants is expected to generate 49.81 times more return on investment than Xeris Pharmaceuticals. However, Cingulate Warrants is 49.81 times more volatile than Xeris Pharmaceuticals. It trades about 0.16 of its potential returns per unit of risk. Xeris Pharmaceuticals is currently generating about 0.1 per unit of risk. If you would invest 2.00 in Cingulate Warrants on August 30, 2024 and sell it today you would earn a total of 1.50 from holding Cingulate Warrants or generate 75.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 86.51% |
Values | Daily Returns |
Cingulate Warrants vs. Xeris Pharmaceuticals
Performance |
Timeline |
Cingulate Warrants |
Xeris Pharmaceuticals |
Cingulate Warrants and Xeris Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cingulate Warrants and Xeris Pharmaceuticals
The main advantage of trading using opposite Cingulate Warrants and Xeris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Xeris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeris Pharmaceuticals will offset losses from the drop in Xeris Pharmaceuticals' long position.Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd |
Xeris Pharmaceuticals vs. Protalix Biotherapeutics | Xeris Pharmaceuticals vs. Seres Therapeutics | Xeris Pharmaceuticals vs. Cidara Therapeutics | Xeris Pharmaceuticals vs. Immunitybio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |